Biotechnology Assets Market Cap

Biotechnology Assets has a market cap or net worth of €15.55 million as of March 2, 2026. Its market cap has decreased by -31.86% in one year.

Market Cap

15.55M

Enterprise Value

17.11M

Revenue

3.05M

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.21

Market Cap Chart

Since May 29, 2018, Biotechnology Assets's market cap has decreased from 74.66M to 15.55M, a decrease of -79.18%. That is a compound annual growth rate of -18.32%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2026	15.55M	11.22%
Dec 31, 2025	13.98M	-23.55%
Dec 31, 2024	18.28M	-20.03%
Dec 29, 2023	22.86M	84.02%
Dec 30, 2022	12.42M	-40.67%
Dec 30, 2021	20.94M	-3.86%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Grifols	6.69B
Laboratorios Farmaceuticos Rovi	4.33B
Almirall	2.76B
Faes Farma	1.52B
Oryzon Genomics	253.91M
Prim, S.A.	231.42M
Atrys Health	224.59M
Laboratorio Reig Jofre	214.87M

Market Cap Rankings